Huntsville, Ala. — October 6, 2016 —iCubate®, a molecular diagnostic company, has formed a Scientific Advisory Board to advance the company’s goal of developing and marketing technologies and products for personalized diagnostics. The advisory board will work with iCubate’s board and management team to ensure the company continues to develop innovative products that meet market demand and are positioned for long-term growth and success.

“iCubate is privileged to have these individuals as part of our Scientific Advisory Board. The advice and guidance offered by this group of distinguished scientists will be of tremendous value as we position the company’s future scientific direction,” said Carter Wells, CEO of iCubate®.

The group will meet periodically to discuss scientific advancements, market trends and product pipelines in addition to the overall direction of the company.

The Scientific Advisory Board members are below (full biographical sketch can be found at www.icubate.com):

Paul A. Granato, Ph.D., DABMM, FAAM is the Director of Microbiology at the Laboratory Alliance of Central New York and Professor of Pathology at SUNY Upstate Medical University. Dr. Granato earned his Ph.D. in microbiology and molecular biology from Syracuse University after graduating from Le Moyne College majoring in biology and chemistry. He then trained in a two-year post-doctoral fellowship program in clinical microbiology and infectious diseases at Columbia University, College of Physicians & Surgeons. He has also served on the Editorial Board of Journal of Clinical Microbiology and has been a co-editor for Clinical Microbiology Newsletter. Currently, he directs two consolidated clinical microbiology laboratories in Central New York, five laboratories scattered throughout Florida, as well as being actively involved in various clinical research studies.

Richard M. Myers, Ph.D. is the President and Science Director at HudsonAlpha Institute for Biotechnology in Huntsville, Alabama. Dr. Myers received his BS in biochemistry from the University of Alabama and his PhD in biochemistry from the University of California, Berkeley. After completing his postdoctoral training at Harvard University, he joined the faculty of the University of California, San Francisco, Medical Center. After his service at UCSF, he served as professor and chair in the department of genetics at Stanford University. Work in Myers’ Stanford Human Genome Center contributed more than 10 percent of the data for the public Human Genome Project. In 2008 Dr. Myers joined HudsonAlpha as President and Science Director. With 35 years’ experience in genetics and genomics, Dr. Myers leads the Institute, supplying strategic oversight for the research enterprise, including sustaining a large, active laboratory. Dr. Myers is also a founder of two life sciences start-up companies, Kailos Genetics and IMIDomics.

Fran White is founder and President of MDC Associates, a FDA/ISO regulatory and quality assurance consulting company providing a broad range of support services to the in vitro diagnostic industry.   Prior to founding MDC Associates, Ms. White worked in the field of medical clinical microbiology and then joined Gibco Laboratories. At Gibco Laboratories, Ms. White served in a variety of leadership roles in regulatory affairs, quality assurance customer and technical services.

“iCubate is a strong, young company with a novel technology and platform. It is an honor to serve with the other members of this advisory board and be a part of the company’s overall success,” Dr. Granato remarked.

Jian Han, MD, PhD, iCubate’s founder, Chairman of the Board, President and Chief Scientific Officer, added, “The iCubate Scientific Advisory Board brings a wealth of expertise from a wide variety of backgrounds. As the company moves forward, we look forward to the counsel provided by Dr. Granato, Ms. White and Dr. Myers.”

 

About iCubate®
iCubate®, Incorporated is a privately-held molecular diagnostic company based in Huntsville, Ala. The company is housed in the HudsonAlpha Institute for Biotechnology. The integrated iCubate System enables extraction, multiplexed amplification and detection automatically in a closed and disposable cassette. Currently, iCubate® products are available for non-clinical, research-use only. See
icubate.com for more information.

About HudsonAlpha: HudsonAlpha Institute for Biotechnology is a nonprofit institute dedicated to innovating in the field of genomic technology and sciences across a spectrum of biological challenges. Opened in 2008, its mission is four-fold: sparking scientific discoveries that can impact human health and well-being; bringing genomic medicine into clinical care; fostering life sciences entrepreneurship and business growth; and encouraging the creation of a genomics-literate workforce and society. The HudsonAlpha biotechnology campus consists of 152 acres nestled within Cummings Research Park, the nation’s second largest research park. Designed to be a hothouse of biotech economic development, HudsonAlpha’s state-of-the-art facilities co-locate nonprofit scientific researchers with entrepreneurs and educators. The relationships formed on the HudsonAlpha campus encourage collaborations that produce advances in medicine and agriculture. Under the leadership of Dr. Richard M. Myers, a key collaborator on the Human Genome Project, HudsonAlpha has become a national and international leader in genetics and genomics research and biotech education, and includes more than 30 diverse biotech companies on campus. To learn more about HudsonAlpha, visit:  http://hudsonalpha.org/.

Media contact:

Margetta Thomas

Tel: 256-327-0425

Email: mthomas@hudsonalpha.org

 

 

Navigation

Color Skin